Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS

Overview of attention for article published in Journal of Neuroinflammation, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,029 followers.

Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS. https://t.co/m7ts3YJ1P8

Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS. https://t.co/qDWbx4MKlv

Lymphoma drug, AMD3100, shows promise in #ALS #MND mouse model https://t.co/KHJF1p9QyQ

Cxcr-4 blockade stimulates neurogenesis in ALS model https://t.co/34CLPJUxZ8 blocks neuroinflammation https://t.co/2gqBwfb0gL

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.